Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Next Generation Cancer Diagnostics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
PerkinElmer
Illumina
Hologic
Almac Group
F Hoffmann-La Roche Ltd
Janssen Global Services
Agilent Technologies
Novartis AG
Opko Health
Myriad Genetics
GE Healthcare
Sysmex Corporation
Abbott
Genomic Health
Qiagen
By Type:
DNA Microarrays
Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Next Generation Sequencing
Protein Microarrays
QPCR & Multiplexing
By Application:
Breast Cancer
Cervical Cancer
Others
Colorectal Cancer
Lung Cancer
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Next Generation Cancer Diagnostics Market Overview 2018-2029
-
1.1 China Next Generation Cancer Diagnostics Industry Development Overview
-
1.2 China Next Generation Cancer Diagnostics Industry Development History
-
1.3 China Next Generation Cancer Diagnostics Industry Market Size (2018-2029)
-
1.4 China Next Generation Cancer Diagnostics Market Analysis by Type from Production Side
-
1.4.1 China Next Generation Cancer Diagnostics Production Volume, Production Value and Growth Rate of DNA Microarrays (2018-2029)
-
1.4.2 China Next Generation Cancer Diagnostics Production Volume, Production Value and Growth Rate of Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) (2018-2029)
-
1.4.3 China Next Generation Cancer Diagnostics Production Volume, Production Value and Growth Rate of Next Generation Sequencing (2018-2029)
-
1.4.4 China Next Generation Cancer Diagnostics Production Volume, Production Value and Growth Rate of Protein Microarrays (2018-2029)
-
1.4.5 China Next Generation Cancer Diagnostics Production Volume, Production Value and Growth Rate of QPCR & Multiplexing (2018-2029)
-
1.5 China Next Generation Cancer Diagnostics Market Analysis by Application from Consumption End
-
1.5.1 China Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)
-
1.5.2 China Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Cervical Cancer (2018-2029)
-
1.5.3 China Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.4 China Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Colorectal Cancer (2018-2029)
-
1.5.5 China Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)
-
1.6 China Next Generation Cancer Diagnostics Market Analysis by Region
-
1.6.1 North China Next Generation Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Next Generation Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Next Generation Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Next Generation Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Next Generation Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Next Generation Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Next Generation Cancer Diagnostics Market Size and Growth Rate from 2018-2029
Chapter 2 China Next Generation Cancer Diagnostics Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Next Generation Cancer Diagnostics Market Status and Competition at home and abroad in 2023
-
2.2.2 China Next Generation Cancer Diagnostics Market Status and Competition Analysis in 2023
-
2.2.3 China Next Generation Cancer Diagnostics Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Next Generation Cancer Diagnostics Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Next Generation Cancer Diagnostics Industry Development
Chapter 3 Next Generation Cancer DiagnosticsIndustry Chain Analysis
-
3.1 Next Generation Cancer Diagnostics Industry Chain
-
3.2 Next Generation Cancer Diagnostics Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Next Generation Cancer Diagnostics Market
-
3.3 Next Generation Cancer Diagnostics Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Next Generation Cancer Diagnostics Market
Chapter 4 China Next Generation Cancer Diagnostics Market, by Type
-
4.1 China Next Generation Cancer Diagnostics Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Next Generation Cancer Diagnostics Total Production Volume and Growth Rate from Production Side
-
4.5 China Next Generation Cancer Diagnostics Production Volume and Growth Rate, by Type
-
4.5.1 China Next Generation Cancer Diagnostics Production Volume and Growth Rate of DNA Microarrays
-
4.5.2 China Next Generation Cancer Diagnostics Production Volume and Growth Rate of Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
-
4.5.3 China Next Generation Cancer Diagnostics Production Volume and Growth Rate of Next Generation Sequencing
-
4.5.4 China Next Generation Cancer Diagnostics Production Volume and Growth Rate of Protein Microarrays
-
4.5.5 China Next Generation Cancer Diagnostics Production Volume and Growth Rate of QPCR & Multiplexing
Chapter 5 China Next Generation Cancer Diagnostics Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Next Generation Cancer Diagnostics Total Market Size and Growth Rate from Consumption End
-
5.5 China Next Generation Cancer Diagnostics Market Size and Growth Rate, by Application
-
5.5.1 China Next Generation Cancer Diagnostics Market Size and Growth Rate of Breast Cancer
-
5.5.2 China Next Generation Cancer Diagnostics Market Size and Growth Rate of Cervical Cancer
-
5.5.3 China Next Generation Cancer Diagnostics Market Size and Growth Rate of Others
-
5.5.4 China Next Generation Cancer Diagnostics Market Size and Growth Rate of Colorectal Cancer
-
5.5.5 China Next Generation Cancer Diagnostics Market Size and Growth Rate of Lung Cancer
Chapter 6 China Next Generation Cancer Diagnostics Market, by Region
-
6.1 China Next Generation Cancer Diagnostics Production Volume and Production Value, by Region
-
6.2 China Next Generation Cancer Diagnostics Sales Volume and Sales Value, by Region
Chapter 7 North China Next Generation Cancer Diagnostics Market Analysis
-
7.1 North China Next Generation Cancer Diagnostics Market, by Type
-
7.2 North China Next Generation Cancer Diagnostics Market, by Application
Chapter 8 Central China Next Generation Cancer Diagnostics Market Analysis
-
8.1 Central China Next Generation Cancer Diagnostics Market, by Type
-
8.2 Central China Next Generation Cancer Diagnostics Market, by Application
Chapter 9 South China Next Generation Cancer Diagnostics Market Analysis
-
9.1 South China Next Generation Cancer Diagnostics Market, by Type
-
9.2 South China Next Generation Cancer Diagnostics Market, by Application
Chapter 10 East China Next Generation Cancer Diagnostics Market Analysis
-
10.1 East China Next Generation Cancer Diagnostics Market, by Type
-
10.2 East China Next Generation Cancer Diagnostics Market, by Application
Chapter 11 Northeast China Next Generation Cancer Diagnostics Market Analysis
-
11.1 Northeast China Next Generation Cancer Diagnostics Market, by Type
-
11.2 Northeast China Next Generation Cancer Diagnostics Market, by Application
Chapter 12 Southwest China Next Generation Cancer Diagnostics Market Analysis
-
12.1 Southwest China Next Generation Cancer Diagnostics Market, by Type
-
12.2 Southwest China Next Generation Cancer Diagnostics Market, by Application
Chapter 13 Northwest China Next Generation Cancer Diagnostics Market Analysis
-
13.1 Northwest China Next Generation Cancer Diagnostics Market, by Type
-
13.2 Northwest China Next Generation Cancer Diagnostics Market, by Application
Chapter 14 Company Profiles
-
14.1 PerkinElmer
-
14.1.1 PerkinElmer Company Profile
-
14.1.2 PerkinElmer Next Generation Cancer Diagnostics Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Illumina
-
14.2.1 Illumina Company Profile
-
14.2.2 Illumina Next Generation Cancer Diagnostics Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Hologic
-
14.3.1 Hologic Company Profile
-
14.3.2 Hologic Next Generation Cancer Diagnostics Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Almac Group
-
14.4.1 Almac Group Company Profile
-
14.4.2 Almac Group Next Generation Cancer Diagnostics Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 F Hoffmann-La Roche Ltd
-
14.5.1 F Hoffmann-La Roche Ltd Company Profile
-
14.5.2 F Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Janssen Global Services
-
14.6.1 Janssen Global Services Company Profile
-
14.6.2 Janssen Global Services Next Generation Cancer Diagnostics Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Agilent Technologies
-
14.7.1 Agilent Technologies Company Profile
-
14.7.2 Agilent Technologies Next Generation Cancer Diagnostics Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Novartis AG
-
14.8.1 Novartis AG Company Profile
-
14.8.2 Novartis AG Next Generation Cancer Diagnostics Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Opko Health
-
14.9.1 Opko Health Company Profile
-
14.9.2 Opko Health Next Generation Cancer Diagnostics Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Myriad Genetics
-
14.10.1 Myriad Genetics Company Profile
-
14.10.2 Myriad Genetics Next Generation Cancer Diagnostics Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 GE Healthcare
-
14.11.1 GE Healthcare Company Profile
-
14.11.2 GE Healthcare Next Generation Cancer Diagnostics Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Sysmex Corporation
-
14.12.1 Sysmex Corporation Company Profile
-
14.12.2 Sysmex Corporation Next Generation Cancer Diagnostics Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Abbott
-
14.13.1 Abbott Company Profile
-
14.13.2 Abbott Next Generation Cancer Diagnostics Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Genomic Health
-
14.14.1 Genomic Health Company Profile
-
14.14.2 Genomic Health Next Generation Cancer Diagnostics Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Qiagen
-
14.15.1 Qiagen Company Profile
-
14.15.2 Qiagen Next Generation Cancer Diagnostics Market Performance
-
14.15.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Next Generation Cancer Diagnostics Industry Research Conclusions
-
15.2 Next Generation Cancer Diagnostics Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Next Generation Cancer Diagnostics Industry Market Size (2018-2029)
-
Figure China Next Generation Cancer Diagnostics Production Volume, Production Value and Growth Rate of DNA Microarrays (2018-2029)
-
Figure China Next Generation Cancer Diagnostics Production Volume, Production Value and Growth Rate of Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) (2018-2029)
-
Figure China Next Generation Cancer Diagnostics Production Volume, Production Value and Growth Rate of Next Generation Sequencing (2018-2029)
-
Figure China Next Generation Cancer Diagnostics Production Volume, Production Value and Growth Rate of Protein Microarrays (2018-2029)
-
Figure China Next Generation Cancer Diagnostics Production Volume, Production Value and Growth Rate of QPCR & Multiplexing (2018-2029)
-
Figure China Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)
-
Figure China Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Cervical Cancer (2018-2029)
-
Figure China Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Colorectal Cancer (2018-2029)
-
Figure China Next Generation Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)
-
Figure North China Next Generation Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
Figure Central China Next Generation Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
Figure South China Next Generation Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
Figure East China Next Generation Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Next Generation Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Next Generation Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Next Generation Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
Figure Next Generation Cancer Diagnostics Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Next Generation Cancer Diagnostics Market Share by Type in 2018
-
Figure China Next Generation Cancer Diagnostics Market Share by Type in 2023
-
Figure China Next Generation Cancer Diagnostics Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Next Generation Cancer Diagnostics Production Volume and Growth Rate of DNA Microarrays (2018-2023)
-
Figure China Next Generation Cancer Diagnostics Production Volume and Growth Rate of Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) (2018-2023)
-
Figure China Next Generation Cancer Diagnostics Production Volume and Growth Rate of Next Generation Sequencing (2018-2023)
-
Figure China Next Generation Cancer Diagnostics Production Volume and Growth Rate of Protein Microarrays (2018-2023)
-
Figure China Next Generation Cancer Diagnostics Production Volume and Growth Rate of QPCR & Multiplexing (2018-2023)
-
Figure China Next Generation Cancer Diagnostics Market Share by Application in 2018
-
Figure China Next Generation Cancer Diagnostics Market Share by Application in 2023
-
Figure China Next Generation Cancer Diagnostics Total Market Size and Growth Rate from Consumption End
-
Figure China Next Generation Cancer Diagnostics Market Size and Growth Rate of Breast Cancer (2018-2023)
-
Figure China Next Generation Cancer Diagnostics Market Size and Growth Rate of Cervical Cancer (2018-2023)
-
Figure China Next Generation Cancer Diagnostics Market Size and Growth Rate of Others (2018-2023)
-
Figure China Next Generation Cancer Diagnostics Market Size and Growth Rate of Colorectal Cancer (2018-2023)
-
Figure China Next Generation Cancer Diagnostics Market Size and Growth Rate of Lung Cancer (2018-2023)
-
Table China Next Generation Cancer Diagnostics Production Volume by Region (2018-2023)
-
Table China Next Generation Cancer Diagnostics Production Volume Share by Region (2018-2023)
-
Figure China Next Generation Cancer Diagnostics Production Volume Share by Region (2018-2023)
-
Table China Next Generation Cancer Diagnostics Production Value by Region (2018-2023)
-
Table China Next Generation Cancer Diagnostics Production Value Share by Region (2018-2023)
-
Figure China Next Generation Cancer Diagnostics Production Value Share by Region (2018-2023)
-
Table China Next Generation Cancer Diagnostics Sales Volume by Region (2018-2023)
-
Table China Next Generation Cancer Diagnostics Sales Volume Share by Region (2018-2023)
-
Figure China Next Generation Cancer Diagnostics Sales Volume Share by Region (2018-2023)
-
Table China Next Generation Cancer Diagnostics Sales Value by Region (2018-2023)
-
Table China Next Generation Cancer Diagnostics Sales Value Share by Region (2018-2023)
-
Figure China Next Generation Cancer Diagnostics Sales Value Share by Region (2018-2023)
-
Table North China Next Generation Cancer Diagnostics Production Volume by Type (2018-2023)
-
Table North China Next Generation Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Figure North China Next Generation Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Table North China Next Generation Cancer Diagnostics Sales Volume by Application (2018-2023)
-
Table North China Next Generation Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Figure North China Next Generation Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Table Central China Next Generation Cancer Diagnostics Production Volume by Type (2018-2023)
-
Table Central China Next Generation Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Figure Central China Next Generation Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Table Central China Next Generation Cancer Diagnostics Sales Volume by Application (2018-2023)
-
Table Central China Next Generation Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Figure Central China Next Generation Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Table South China Next Generation Cancer Diagnostics Production Volume by Type (2018-2023)
-
Table South China Next Generation Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Figure South China Next Generation Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Table South China Next Generation Cancer Diagnostics Sales Volume by Application (2018-2023)
-
Table South China Next Generation Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Figure South China Next Generation Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Table East China Next Generation Cancer Diagnostics Production Volume by Type (2018-2023)
-
Table East China Next Generation Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Figure East China Next Generation Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Table East China Next Generation Cancer Diagnostics Sales Volume by Application (2018-2023)
-
Table East China Next Generation Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Figure East China Next Generation Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Table Northeast China Next Generation Cancer Diagnostics Production Volume by Type (2018-2023)
-
Table Northeast China Next Generation Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Figure Northeast China Next Generation Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Table Northeast China Next Generation Cancer Diagnostics Sales Volume by Application (2018-2023)
-
Table Northeast China Next Generation Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Next Generation Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Table Southwest China Next Generation Cancer Diagnostics Production Volume by Type (2018-2023)
-
Table Southwest China Next Generation Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Figure Southwest China Next Generation Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Table Southwest China Next Generation Cancer Diagnostics Sales Volume by Application (2018-2023)
-
Table Southwest China Next Generation Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Next Generation Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Table Northwest China Next Generation Cancer Diagnostics Production Volume by Type (2018-2023)
-
Table Northwest China Next Generation Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Figure Northwest China Next Generation Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Table Northwest China Next Generation Cancer Diagnostics Sales Volume by Application (2018-2023)
-
Table Northwest China Next Generation Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Next Generation Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Table PerkinElmer Company Profile
-
Table PerkinElmer Next Generation Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Illumina Company Profile
-
Table Illumina Next Generation Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Hologic Company Profile
-
Table Hologic Next Generation Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Almac Group Company Profile
-
Table Almac Group Next Generation Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table F Hoffmann-La Roche Ltd Company Profile
-
Table F Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Janssen Global Services Company Profile
-
Table Janssen Global Services Next Generation Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Agilent Technologies Company Profile
-
Table Agilent Technologies Next Generation Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Next Generation Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Opko Health Company Profile
-
Table Opko Health Next Generation Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Myriad Genetics Company Profile
-
Table Myriad Genetics Next Generation Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table GE Healthcare Company Profile
-
Table GE Healthcare Next Generation Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Sysmex Corporation Company Profile
-
Table Sysmex Corporation Next Generation Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Abbott Company Profile
-
Table Abbott Next Generation Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Genomic Health Company Profile
-
Table Genomic Health Next Generation Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Qiagen Company Profile
-
Table Qiagen Next Generation Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
